Finance

Lists
688575:SHA
Shenzhen YHLO Biotech Co Ltd
CNยฅ10.55
-0.66%
(-0.070) 1D
Nov 17, 3:00:00โ€ฏPM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688575...
Open
CNยฅ10.60
High
CNยฅ10.75
Low
CNยฅ10.38
Mkt. cap
6.07B
Avg. vol.
9.68M
Volume
4.80M
Dividend
0.20%
Quarterly dividend
CNยฅ0.01
Ex-dividend date
Jun 12, 2026
P/E ratio
55.84
52-wk high
CNยฅ17.00
52-wk low
CNยฅ8.34
EPS
CNยฅ0.19
No. of employees
2K
Open
CNยฅ10.60
High
CNยฅ10.75
Low
CNยฅ10.38
Mkt. cap
6.07B
Avg. vol.
9.68M
Volume
4.80M
Dividend
0.20%
Quarterly dividend
CNยฅ0.01
Ex-dividend date
Jun 12, 2026
P/E ratio
55.84
52-wk high
CNยฅ17.00
52-wk low
CNยฅ8.34
EPS
CNยฅ0.19
No. of employees
2K
News stories
From web sources and news partners
About Shenzhen YHLO Biotech Co Ltd
CEO-
Employees1.69K
FoundedSep 17, 2008
Headquarters-
SectorHealth Care
IndustryMedical device
Websiteszyhlo.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
523.91M
397.82M
490.14M
540.79M
Cost of goods sold
161.40M
150.01M
201.54M
178.97M
Cost of revenue
161.40M
150.01M
201.54M
178.97M
Research and development expenses
93.33M
65.92M
68.74M
76.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
215.15M
145.91M
150.08M
172.94M
Operating expense
331.34M
204.45M
231.02M
244.53M
Total operating expenses
492.74M
354.45M
432.56M
423.50M
Operating income
31.18M
43.37M
57.58M
117.30M
Other non operating income
-191.51K
-16.80M
16.10M
-14.20M
EBT including unusual items
30.00M
17.84M
57.13M
85.29M
EBT excluding unusual items
22.04M
23.76M
60.42M
111.30M
Income tax expense
16.58M
117.28K
3.23M
11.23M
Effective tax rate
55.28%
0.66%
5.66%
13.17%
Other operating expenses
18.27M
-4.44M
10.02M
-6.65M
Net income
-37.08M
17.95M
52.18M
73.42M
Net profit margin
-7.08%
4.51%
10.65%
13.58%
Earnings per share
-
-
-
-
Interest and investment income
2.36M
1.60M
1.97M
2.27M
Interest expense
-8.29M
-4.41M
-6.44M
-2.84M
Net interest expenses
-5.94M
-2.80M
-4.48M
-578.35K
Depreciation and amortization charges
-
-
-
-
EBITDA
102.18M
114.37M
133.25M
188.30M
Gain or loss from assets sale
336.41K
-
254.58K
-254.58K
Upcoming events
AI content may include mistakes. Learn more
Google apps